Heparin Market

Heparin Market by Types (Low Molecular Weight Heparin, Ultra-Low Molecular Weight Heparin, and Unfractionated Heparin), Administrations (Intravenous and Subcutaneous), Applications (Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, and Others), End-Users (Outpatient and Inpatient) and Regions (Asia Pacific, North America, Latin America, Europe and Middle East & Africa)- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: MC-1264
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 187
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global heparin market size was valued at USD 6.9 billion in 2020 and is anticipated to expand at a CAGR of 1.5% during the forecast period, 2021-2028. The growth of the market is attributed to the rising number of accidents along with their related surgeries and the increase in number of cardiovascular disorders & venous thromboembolism.
 

Heparin Market Key Takeaways


Heparin is a blood thinner medication used as an anticoagulant specifically used in the diagnosis of unstable angina and heart attacks. Heparin is normally injected into the patient’s vein or through the skin. They can be used for the treatment of blood clotting disorders. They can also be used in the prevention of blood clots during surgery, during blood transfusions, during dialysis, when collecting blood samples and when a person is paralyzed for long periods of time. Other applications include kidney dialysis machines and test tubes for their storage. According to the World Health Organization or the WHO along with the Centers for Disease Control and Prevention or the CDC, more than 900,000 people living in the United States of America have been affected by pulmonary embolism and deep vein thrombosis in 2018 and this will increase exponentially after the COVID-19 pandemic. The preliminary examination to treat these diseases is done with the help of heparin.

The COVID-19 pandemic has reduced the growth of the global heparin market initially. Researchers and scientists were not able to recognize the co-relation between the coronavirus and heparin. However, upon further research, they were able to identify that heparin can used for vaccination purposes against the coronavirus. This steered to hospitals, clinics, and healthcare laboratories to focus more on the development of heparin for the prevention and treatment of diseases and this led to its market growth in the later stages of the COVID-19 pandemic.

Market Trends, Drivers, Restraints, and Opportunities

  • Increase in occurrences of cardiovascular diseases which can be treated by heparin diagnostics is the primary reason for the projection of boosting the global heparin market growth during the forecast period, 2021-2028.
  • There has been a rapid growth in the investment & funding towards the research & development activities towards heparin from the biopharmaceutical companies, which propels the market expansion in the coming years.
  • High prices for the development of heparin and high cost of services from the company’s perspective is anticipated to hinder the global heparin market growth. This becomes extremely difficult to function in developing countries such as India, South Africa and Brazil where there is limited healthcare infrastructure.
  • Heparin is contraindicated with suspected instances such as the Vaccine-Induced Pro-thrombotic Immune Thrombocytopenia or VIPIT, which can increase the jeopardy of bleeding through the blood clots of the patient. This can hamper the heparin market growth.
  • R&D activities along with studies have shown that unfractionated heparin being a varying chain sizing polymer, can be modified to countereffect certain diseases including the coronavirus. In October 2020, the WHO team had notified that the SARS-CoV-2 vaccination can be done on a certain chain size of heparin and can be mass-produced by the end of the year.

Scope of the Report

The report on the global heparin market size includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Heparin Market Size - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types (Low Molecular Weight Heparin, Ultra-Low Molecular Weight Heparin, and Unfractionated Heparin), Administrations (Intravenous and Subcutaneous), Applications (Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, and Others), End-Users (Outpatient and Inpatient)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast

Key Players Covered in the Report

GlaxoSmithKline plc; Pfizer Inc; Baxter; Leo Pharma A/S; Sanofi; Dr. Reddy’s Laboratories Ltd; Aspen Holdings; B. Braun Medical Inc; Fresenius SE & Co KGaA; and Teva Pharmaceuticals Industries Ltd

 

Global Heparin Market Segment Insights

Low molecular weight heparin segment is estimated to signify the largest market share

Based on types, the global heparin market is segmented into low molecular weight heparin, ultra-low molecular weight heparin, and unfractionated heparin. The low molecular weight heparin segment is expected to constitute the major share of the market in 2019 due to the more predictable and reliable anticoagulant effect with respect to the product. There has also been low incidence towards heparin induced thrombocytopenia which in turns increases the usage of low molecular weight heparin.
Meanwhile the ultra-low molecular weight heparin segment is anticipated to grow with a significant CAGR during the forecast period, 2021-2028. The major reason attributing to this market growth is the commercialization of these products along with improved pharmaceutical effects.
 

Subcutaneous segment is projected to register a large market share

Based on administrations, the global heparin market is bifurcated into intravenous and subcutaneous. The subcutaneous segment is expected to constitute the major share of the market in 2019 and is anticipated to grow with a significant CAGR during the forecast period, 2021-2028 due to the lower costs associated to the patient’s hospitalization. This is also advantageous from the patient’s perspective owing to the increase preference in home care, reduced duration of diagnosis, and the ease in administration.

Coronary artery disease segment is anticipated to register a huge market share

On the basis of applications, the global heparin market is divided into venous thromboembolism, atrial fibrillation, renal impairment, coronary artery disease, and others. The coronary artery disease segment is expected to constitute the major share of the market in 2019. The major reason attributing to this market growth is the rising incidences of multiple heart-related diseases and disorders. One in every three American dies due to cardiovascular diseases and the coronary artery disease falls in this category.

Meanwhile the venous thromboembolism segment is anticipated to grow with a significant CAGR during the forecast period, 2021-2028. There has been a significant increase in the awareness of thrombosis and the treatment using heparin. There has also been websites and blogs specifically dedicated to these disorders and the preventive measures to take as well.
 

Heparin Market by applications

Outpatient segment is expected to propel a large market share

Based on end-users, the global heparin market is bifurcated into outpatient and inpatient. The outpatient segment is expected to constitute the major share of the market in 2019 and is anticipated to grow with a significant CAGR of 2.3% during the forecast period, 2021-2028 due to the lower cost of outpatients compared to that of inpatients. The efficacy for outpatients is also high and with research and development activities, this can only go higher from here.

North America is anticipated to dominate the market

On the basis of regions, the global heparin market is categorized as Asia Pacific, North America, Latin America, Europe and Middle East & Africa. The market in North America is expected to constitute the largest share in 2019. This regional market growth can be attributed to the growing research & development expenditure along with the rising in adoption of the latest technology. The demand of heparin is increasing rapidly in this region due to the presence of the major market players in the market, an advantage no other region has. The cost of expenditure is significantly lower in North America than that of other economies. However, the market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period, 2021-2028, as they have prioritized the cost-efficiency perspective of heparin combined with their growing population.
 

Heparin Market by Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Heparin Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Heparin Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Heparin Market - Supply Chain
  4.5. Global Heparin Market Forecast
     4.5.1. Heparin Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Heparin Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Heparin Market Absolute $ Opportunity
5. Global Heparin Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Heparin Market Size and Volume Forecast by Types
     5.3.1. Low Molecular Weight Heparin
     5.3.2. Ultra-Low Molecular Weight Heparin
     5.3.3. Unfractionated Heparin
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Heparin Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Heparin Market Size and Volume Forecast by Applications
     6.3.1. Venous Thromboembolism
     6.3.2. Atrial Fibrillation
     6.3.3. Renal Impairment
     6.3.4. Coronary Artery Disease
     6.3.5. Others
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Heparin Market Analysis and Forecast by End Users
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by End Users
     7.2.2. Y-o-Y Growth Projections by End Users
  7.3. Heparin Market Size and Volume Forecast by End Users
     7.3.1. Outpatient
     7.3.2. Inpatient
  7.4. Absolute $ Opportunity Assessment by End Users
  7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global Heparin Market Analysis and Forecast by Region
  8.1. Market Trends
  8.2. Introduction
     8.2.1. Basis Point Share (BPS) Analysis by Region
     8.2.2. Y-o-Y Growth Projections by Region
  8.3. Heparin Market Size and Volume Forecast by Region
     8.3.1. North America
     8.3.2. Latin America
     8.3.3. Europe
     8.3.4. Asia Pacific
     8.3.5. Middle East and Africa (MEA)
  8.4. Absolute $ Opportunity Assessment by Region
  8.5. Market Attractiveness/Growth Potential Analysis by Region
  8.6. Global Heparin Demand Share Forecast, 2019-2026
9. North America Heparin Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
  9.2. North America Heparin Market Size and Volume Forecast by Country
     9.2.1. U.S.
     9.2.2. Canada
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. North America Heparin Market Size and Volume Forecast by Types
     9.4.1. Low Molecular Weight Heparin
     9.4.2. Ultra-Low Molecular Weight Heparin
     9.4.3. Unfractionated Heparin
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. North America Heparin Market Size and Volume Forecast by Applications
     9.7.1. Venous Thromboembolism
     9.7.2. Atrial Fibrillation
     9.7.3. Renal Impairment
     9.7.4. Coronary Artery Disease
     9.7.5. Others
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. North America Heparin Market Size and Volume Forecast by End Users
     9.10.1. Outpatient
     9.10.2. Inpatient
  9.11. Basis Point Share (BPS) Analysis by End Users
  9.12. Y-o-Y Growth Projections by End Users
  9.13. Market Attractiveness/Growth Potential Analysis
     9.13.1. By Country
     9.13.2. By Product Type
     9.13.3. By Application
  9.14. North America Heparin Demand Share Forecast, 2019-2026
10. Latin America Heparin Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Latin America Average Pricing Analysis
  10.2. Latin America Heparin Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
  10.4. Latin America Heparin Market Size and Volume Forecast by Types
     10.4.1. Low Molecular Weight Heparin
     10.4.2. Ultra-Low Molecular Weight Heparin
     10.4.3. Unfractionated Heparin
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Latin America Heparin Market Size and Volume Forecast by Applications
     10.7.1. Venous Thromboembolism
     10.7.2. Atrial Fibrillation
     10.7.3. Renal Impairment
     10.7.4. Coronary Artery Disease
     10.7.5. Others
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Latin America Heparin Market Size and Volume Forecast by End Users
     10.10.1. Outpatient
     10.10.2. Inpatient
  10.11. Basis Point Share (BPS) Analysis by End Users
  10.12. Y-o-Y Growth Projections by End Users
  10.13. Market Attractiveness/Growth Potential Analysis
     10.13.1. By Country
     10.13.2. By Product Type
     10.13.3. By Application
  10.14. Latin America Heparin Demand Share Forecast, 2019-2026
11. Europe Heparin Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Europe Average Pricing Analysis
  11.2. Europe Heparin Market Size and Volume Forecast by Country
     11.2.1. Germany
     11.2.2. France
     11.2.3. Italy
     11.2.4. U.K.
     11.2.5. Spain
     11.2.6. Russia
     11.2.7. Rest of Europe
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Europe Heparin Market Size and Volume Forecast by Types
     11.4.1. Low Molecular Weight Heparin
     11.4.2. Ultra-Low Molecular Weight Heparin
     11.4.3. Unfractionated Heparin
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Europe Heparin Market Size and Volume Forecast by Applications
     11.7.1. Venous Thromboembolism
     11.7.2. Atrial Fibrillation
     11.7.3. Renal Impairment
     11.7.4. Coronary Artery Disease
     11.7.5. Others
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Europe Heparin Market Size and Volume Forecast by End Users
     11.10.1. Outpatient
     11.10.2. Inpatient
  11.11. Basis Point Share (BPS) Analysis by End Users
  11.12. Y-o-Y Growth Projections by End Users
  11.13. Market Attractiveness/Growth Potential Analysis
     11.13.1. By Country
     11.13.2. By Product Type
     11.13.3. By Application
  11.14. Europe Heparin Demand Share Forecast, 2019-2026
12. Asia Pacific Heparin Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Asia Pacific Average Pricing Analysis
  12.2. Asia Pacific Heparin Market Size and Volume Forecast by Country
     12.2.1. China
     12.2.2. Japan
     12.2.3. South Korea
     12.2.4. India
     12.2.5. Australia
     12.2.6. Rest of Asia Pacific (APAC)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Asia Pacific Heparin Market Size and Volume Forecast by Types
     12.4.1. Low Molecular Weight Heparin
     12.4.2. Ultra-Low Molecular Weight Heparin
     12.4.3. Unfractionated Heparin
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Asia Pacific Heparin Market Size and Volume Forecast by Applications
     12.7.1. Venous Thromboembolism
     12.7.2. Atrial Fibrillation
     12.7.3. Renal Impairment
     12.7.4. Coronary Artery Disease
     12.7.5. Others
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Asia Pacific Heparin Market Size and Volume Forecast by End Users
     12.10.1. Outpatient
     12.10.2. Inpatient
  12.11. Basis Point Share (BPS) Analysis by End Users
  12.12. Y-o-Y Growth Projections by End Users
  12.13. Market Attractiveness/Growth Potential Analysis
     12.13.1. By Country
     12.13.2. By Product Type
     12.13.3. By Application
  12.14. Asia Pacific Heparin Demand Share Forecast, 2019-2026
13. Middle East & Africa Heparin Market Analysis and Forecast
  13.1. Introduction
     13.1.1. Basis Point Share (BPS) Analysis by Country
     13.1.2. Y-o-Y Growth Projections by Country
     13.1.3. Middle East & Africa Average Pricing Analysis
  13.2. Middle East & Africa Heparin Market Size and Volume Forecast by Country
     13.2.1. Saudi Arabia
     13.2.2. South Africa
     13.2.3. UAE
     13.2.4. Rest of Middle East & Africa (MEA)
  13.3. Absolute $ Opportunity Assessment by Country
  13.4. Middle East & Africa Heparin Market Size and Volume Forecast by Types
     13.4.1. Low Molecular Weight Heparin
     13.4.2. Ultra-Low Molecular Weight Heparin
     13.4.3. Unfractionated Heparin
  13.5. Basis Point Share (BPS) Analysis by Types
  13.6. Y-o-Y Growth Projections by Types
  13.7. Middle East & Africa Heparin Market Size and Volume Forecast by Applications
     13.7.1. Venous Thromboembolism
     13.7.2. Atrial Fibrillation
     13.7.3. Renal Impairment
     13.7.4. Coronary Artery Disease
     13.7.5. Others
  13.8. Basis Point Share (BPS) Analysis by Applications
  13.9. Y-o-Y Growth Projections by Applications
  13.10. Middle East & Africa Heparin Market Size and Volume Forecast by End Users
     13.10.1. Outpatient
     13.10.2. Inpatient
  13.11. Basis Point Share (BPS) Analysis by End Users
  13.12. Y-o-Y Growth Projections by End Users
  13.13. Market Attractiveness/Growth Potential Analysis
     13.13.1. By Country
     13.13.2. By Product Type
     13.13.3. By Application
  13.14. Middle East & Africa Heparin Demand Share Forecast, 2019-2026
14. Competition Landscape
  14.1. Global Heparin Market: Market Share Analysis
  14.2. Heparin Distributors and Customers
  14.3. Heparin Market: Competitive Dashboard
  14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     14.4.1. GlaxoSmithKline plc
     14.4.2. Pfizer Inc
     14.4.3. Baxter
     14.4.4. Leo Pharma A/S
     14.4.5. Sanofi

Segments Covered in the Report
The global heparin market size has been segmented in terms of

Types

  • Low Molecular Weight Heparin
  • Ultra-Low Molecular Weight Heparin
  • Unfractionated Heparin

Administrations

  • Intravenous
  • Subcutaneous

Applications

  • Venous Thromboembolism
  • Atrial Fibrillation
  • Renal Impairment
  • Coronary Artery Disease
  • Others

End-Users

  • Outpatient
  • Inpatient

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • GlaxoSmithKline plc
  • Pfizer Inc
  • Baxter
  • Leo Pharma A/S
  • Sanofi
  • Dr. Reddy’s Laboratories Ltd
  • Aspen Holdings
  • B. Braun Medical Inc
  • Fresenius SE & Co KGaA
  • Teva Pharmaceuticals Industries Ltd

Major players competing in the global heparin market are GlaxoSmithKline plc; Pfizer Inc; Baxter; Leo Pharma A/S; Sanofi; Dr. Reddy’s Laboratories Ltd; Aspen Holdings; B. Braun Medical Inc; Fresenius SE & Co KGaA; and Teva Pharmaceuticals Industries Ltd. These market players are involved in several business strategies such as mergers, acquisitions partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. Fresenius SE & Co KGaA launched heparin sodium in 2018 in the form of ready-to-administer non DEHP bags, improving their portfolio in the global heparin market.
 

Heparin Market by Key Players

Buy Report